SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)
PFE 24.310.0%Oct 30 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: darbyred who wrote (1691)7/27/2001 7:38:32 AM
From: vestor  Read Replies (1) of 1722
 
Reflex causes those who do not think it through to call the sector 'defensive'. The baby boom demographics has some, with good cause, calling the sector a growth sector. We are a little early but now is the time to build a solid portfolio then sit back as Wall Str. recognizes what we see now.

The 20 mg capsule has the lions share of Prozac sales. Barr Labs has six months exclucivity and first to market usually maintains the lions share. Do think DRMD drug menu and FDA submissions very good for BRL. DRMD had great ideas and products but always lacked the $ to adequately promote. BRL is a cash cow with very smart management. Look for great things to come out with this combination. Suggest listening to 8/7 DRMD conf. call. I expect they report their best qtr. in their history.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext